Case Report: Chemotherapy-free treatment with camrelizumab and anlotinib for elderly patients with KRAS and TP53 mutated advanced lung cancer
Background: Lung cancer is a major public health issue and an enormous burden on society in China. Most lung cancers occur in elderly patients with non-small cell lung cancer (NSCLC), and many factors limit their treatment options. Chemotherapy-free therapy can avoid psychological fear, treatment pa...
Saved in:
Main Authors: | Wenbo Qi (Author), Dayong Xi (Author), Yuping Bai (Author), Le Liu (Author), Yanling Ma (Author), Zhenyu Yin (Author), Hao Chen (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2023-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Induction of pancreatic neoplasia in the KRAS/TP53 Oncopig
by: Pinaki Mondal, et al.
Published: (2023) -
Survival Prediction of Patients Treated With Immune Checkpoint Inhibitors via KRAS/TP53/EGFR-Single Gene Mutation
by: Shui Liu, et al.
Published: (2022) -
Quantitative Structure Activity Relationships (QSAR) for Binary Mixtures at Non-Equitoxic Ratios Based on Toxic Ratios-Effects Curves
by: Dayong Tian, et al.
Published: (2013) -
Systematic evaluation of TP53 codon 72 polymorphism associated with onset and progression of oral potentially malignant disorders
by: Huangkai Li, et al.
Published: (2023) -
Tp53 Mutation Inhibits Ubiquitination and Degradation of WISP1 via Down-Regulation of Siah1 in Pancreatic Carcinogenesis
by: Wei Wu, et al.
Published: (2018)